Pasteurella multocida Toxin Aggravates Ligatured-Induced Periodontal Bone Loss and Inflammation via NOD-Like Receptor Protein 3 Inflammasome

被引:1
|
作者
Han, Yineng [1 ,2 ,3 ,4 ]
Gao, Pengfei [5 ,6 ]
Yang, Qiaolin [1 ,2 ,3 ,4 ]
Huang, Yiping [1 ,2 ,3 ,4 ]
Jia, Lingfei [2 ,3 ,4 ,7 ]
Zheng, Yunfei [1 ,2 ,3 ,4 ]
Li, Weiran [1 ,2 ,3 ,4 ]
机构
[1] Peking Univ, Dept Orthodont, Sch & Hosp Stomatol, Beijing 100081, Peoples R China
[2] Natl Clin Res Ctr Oral Dis, Natl Ctr Stomatol, Beijing 100081, Peoples R China
[3] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing 100081, Peoples R China
[4] Natl Clin Res Ctr Oral Dis, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing 100081, Peoples R China
[5] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100081, Peoples R China
[6] Peking Tsinghua Ctr Life Sci, Beijing 100081, Peoples R China
[7] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100081, Peoples R China
基金
中国国家自然科学基金;
关键词
NLRP3; INFLAMMASOME; ACTIVATION; EXPRESSION; MECHANISM; CASPASES; BACTERIA;
D O I
10.1155/2022/3305695
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is reportedly involved in periodontal pathogenesis. Pasteurella multocida toxin (PMT) is the major virulence factor of Pasteurella multocida strains, which belongs to the nonoral gram-negative facultative rods (GNFR). The existence of GNFR and their toxin may aggravate periodontitis. Therefore, it is important to unclose the regulatory mechanisms of PMT in periodontitis. However, the involvement of NLRP3 inflammasome and PMT in periodontitis remain unclear. The results showed that NLRP3 expression was increased in periodontitis mice by immunohistochemical staining and quantitative reverse transcription polymerase chain reaction (qRT-PCR). Nlrp3(-/-) mice showed less periodontal bone loss and lower abundances of Pasteurella multocida by 16S rRNA sequencing. PMT promoted NLRP3 expressions by activating nuclear factor kappa light chain enhancer of B cells (NF-kappa B) pathway and activated NLRP3 inflammasome. This effect was reversed by NLRP3 inhibitor MCC950. Furthermore, PMT aggravated periodontal bone loss and inflammation in WT mice, while MCC950 attenuated periodontal bone loss and inflammation. The Nlrp3(-/-) periodontitis models with PMT local injection showed less bone loss and inflammation compared with WT periodontitis mice after PMT treatment. Taken together, our results showed that PMT aggravates periodontal response to the ligature by promoting NLRP3 expression and activating NLRP3 inflammasome, suggesting that NLRP3 may be an effective target for the treatment of periodontitis caused by GNFR and MCC950 may be a potential drug against this disease.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Prevention of High Fat-induced Podocyte Injury and Glomerular Sclerosis in Mice Lacking Nod-like Receptor Protein 3: Role of Inflammasome Extinction
    Boini, Krishna
    Xia, Min
    Conley, Sabena
    Li, Guangbi
    Gehr, Todd
    Li, Pin-Lan
    FASEB JOURNAL, 2015, 29
  • [42] MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson’s disease
    Yan Zhou
    Ming Lu
    Ren-Hong Du
    Chen Qiao
    Chun-Yi Jiang
    Ke-Zhong Zhang
    Jian-Hua Ding
    Gang Hu
    Molecular Neurodegeneration, 11
  • [43] MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease
    Zhou, Yan
    Lu, Ming
    Du, Ren-Hong
    Qiao, Chen
    Jiang, Chun-Yi
    Zhang, Ke-Zhong
    Ding, Jian-Hua
    Hu, Gang
    MOLECULAR NEURODEGENERATION, 2016, 11
  • [44] Atheroprone Flow Activation of the Sterol Regulatory Element Binding Protein 2 and Nod-Like Receptor Protein 3 Inflammasome Mediates Focal Atherosclerosis
    Abe, Jun-ichi
    Berk, Bradford C.
    CIRCULATION, 2013, 128 (06) : 579 - 582
  • [45] Loss of Type 2 Bone Morphogenetic Protein Receptor Activates NOD-Like Receptor Family Protein 3/Gasdermin E-Mediated Pyroptosis in Pulmonary Arterial Hypertension
    Tian, Xiao-ting
    Peng, Zhou-yang-fan
    Wu, Yu-si
    Cao, Yuan-yuan
    Li, Xue-chun
    Li, Ying
    Tang, Si-Yuan
    Chen, Alex F.
    Li, Xiao-hui
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (03):
  • [46] Negative regulation of Nod-like receptor protein 3 inflammasome activation by T cell Ig mucin-3 protects against peritonitis
    Wang, Wei
    Shi, Qingzhu
    Dou, Shuaijie
    Li, Ge
    Shi, Xinhui
    Jiang, Xingwei
    Wang, Zhiding
    Yu, Dandan
    Chen, Guojiang
    Wang, Renxi
    Xiao, He
    Hou, Chunmei
    Feng, Jiannan
    Shen, Beifen
    Ma, Yuanfang
    Han, Gencheng
    IMMUNOLOGY, 2018, 153 (01) : 71 - 83
  • [47] Influencing Mechanism of Nod-Like Receptor Protein 3 Inflammasome Activation in A375 Cell Activity in Human Cutaneous Malignant Melanoma
    Sulaiman, Akebaier
    Lv, Jin
    Fan, Junwei
    Abuliezi, Reyila
    Zhang, Qian
    Wan, Xuefeng
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [48] Influencing Mechanism of Nod-Like Receptor Protein 3 Inflammasome Activation in A375 Cell Activity in Human Cutaneous Malignant Melanoma
    Sulaiman, Akebaier
    Lv, Jin
    Fan, Junwei
    Abuliezi, Reyila
    Zhang, Qian
    Wan, Xuefeng
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [49] Interleukin-1α and tumor necrosis factor α as an inducer for reactive-oxygen-species-mediated NOD-like receptor protein 1/NOD-like receptor protein 3 inflammasome activation in mononuclear blood cells from individuals with chronic insomnia disorder
    Aghelan, Zahra
    Karima, Saeed
    Khazaie, Habibolah
    Abtahi, Seyed Hosein
    Farokhi, Ali Reza
    Rostampour, Masoumeh
    Bahrehmand, Fariborz
    Khodarahmi, Reza
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (12) : 3647 - 3657
  • [50] Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages
    Gicquel, Thomas
    Victoni, Tatiana
    Fautrel, Alain
    Robert, Sacha
    Gleonnec, Florence
    Guezingar, Marie
    Couillin, Isabelle
    Catros, Veronique
    Boichot, Elisabeth
    Lagente, Vincent
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2014, 41 (04): : 279 - 286